ReviewChemical record (New York, N.Y.)2026
Nanozymes in Point-of-Care Testing: Classification, Biosensing Strategies, and Integrated Applications.
Review in Chemical record (New York, N.Y.), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Nanozymes, a class of artificial enzyme mimics, combine the catalytic properties of natural enzymes with the high stability inherent to nanomaterials. This unique combination of features has established them as core functional materials in advanced fields such as biosensing and disease therapy. This review systematically examines recent advances in point-of-care testing (POCT) biosensors based on nanozymes, focusing on three fundamental aspects: the first is the classification of nanozymes; the second is the mechanism of action of nanozymes in biomolecular recognition, signal conversion and output, and signal amplification processes; and the third is the innovative applications of nanozyme-based POCT technology in biomarker detection. By in-depth analyzing the multifunctional roles of nanozymes as recognition units, signal converters, and signal amplifiers, this article outlines the design strategies for constructing nanozyme-integrated POCT biosensors, with particular emphasis on the functional positioning of nanozymes within these systems. Furthermore, the application potential of nanozyme-based POCT in detecting diverse biomolecules is discussed, providing a reference for newcomers and researchers to quickly grasp current trends in the field. Finally, key challenges are highlighted, and future research directions are proposed.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.